Original Source(s)
Related Content
FDA Expands Afrezza to Pediatric Diabetes
The decision was supported by the phase 3 INHALE-1 trial and additional long-term safety, efficacy, and exposure data.
May 29, 2026
-
3 min
Mutational Signatures May Define Oral Cancers
Researchers identified endogenous mutational and immune-response patterns in oral cancers arising without exposure to tobacco, alcohol, or human papillomavirus infections.
May 26, 2026
-
3 min
Ensitrelvir Reduced COVID After Household Exposure
In SCORPIO-PEP, symptomatic COVID-19 occurred in 3% vs 9% of household contacts by day 10.
May 27, 2026
-
6 min